PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...

Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...

The US Food and Drug Administration (FDA) has approved xanomeline and trospium chloride capsules (Cobenfy) for the treatment of schizophrenia in adults. The drug is the first antipsychotic treatment ...

Alembic Pharma gets US FDA approval for paliperidone ER tablets: Our Bureau, Bengaluru Monday, September 30, 2024, 11:30 Hrs [IST] Alembic Pharmaceuticals has received final appro ...

Investors are increasingly backing stocks, expecting them to outperform bonds as optimism grows from Fed rate cuts. ... Read ...

True expertise is built slowly, through years of dedicated study, self-questioning, and experimentation. The quiet experts – ...

The FDA approved a new drug for schizophrenia. Discrimination is stressing Chinese Americans and damaging their mental health.

Bristol Myers Squibb climbed 1.5% after the FDA approved its schizophrenia drug. This marks the first new treatment option ...

The stable phase of schizophrenia is the period during which psychotic symptoms are less severe and may even be absent. Some patients have nonpsychotic symptoms like anxiety, tension, depression ...

AT&T Inc (NYSE:T) announced Monday that it plans to sell its 70% ownership in satellite TV provider DirecTV to private equity firm TPG for $7.6 billion, marking the telecom giant's exit from a ...

Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes Varun ...

Former PM Ehud Olmert confirms Israel's role in the 2008 killing of Hezbollah's Mughniyeh, breaking 16-year silence on covert Syria mission. The Mitvim Institute's 2024 Foreign Policy Index ...